NCT05743374 Micronutrient and Additive Modifications May Optimize Diet To Health
| NCT ID | NCT05743374 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Region Skane |
| Condition | Ulcerative Colitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2024-04-02 |
| Primary Completion | 2029-06-26 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2024-04-02 with a primary completion date of 2029-06-26.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective clinical intervention trial where patients with moderately active ulcerative colitis are randomized to either normal healthy diet or a diet with elimination of emulsifying agents within the E 400-group with special respect to carragenan, CMC and polysorbates. At study start and end after one month their diet, clinical characteristics and microbiota will be analysed. The hypotheses are that their disease activity measured with calprotectin and their microbiota will improve after intervention.
Eligibility Criteria
Inclusion Criteria: * Ulcerative colitis, * Moderately active * Stable medication Exclusion Criteria: * Severe disease * Recent surgery * Proctitis * Pregancy * Treatment with antibiotics * Difficulties in understanding the information about the study * Multimorbidity that makes it impossible to participate
Contact & Investigator
Klas Sjöberg, Prof
PRINCIPAL INVESTIGATOR
Dept of Gastroenterology, SUS, Malmö, Sweden
Frequently Asked Questions
Who can join the NCT05743374 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Ulcerative Colitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05743374 currently recruiting?
Yes, NCT05743374 is actively recruiting participants. Contact the research team at klas.sjoberg@med.lu.se for enrollment information.
Where is the NCT05743374 trial being conducted?
This trial is being conducted at Malmö, Sweden.
Who is sponsoring the NCT05743374 clinical trial?
NCT05743374 is sponsored by Region Skane. The principal investigator is Klas Sjöberg, Prof at Dept of Gastroenterology, SUS, Malmö, Sweden. The trial plans to enroll 70 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.